WallStSmart

Kenvue Inc. (KVUE)vsProcter & Gamble Company (PG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Procter & Gamble Company generates 467% more annual revenue ($86.72B vs $15.29B). PG leads profitability with a 19.2% profit margin vs 10.6%. KVUE appears more attractively valued with a PEG of 1.42. KVUE earns a higher WallStSmart Score of 68/100 (B-).

KVUE

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.22

PG

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 8.5Value: 3.3Quality: 6.0
Piotroski: 4/9Altman Z: 3.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$9.91

Current Price

$17.71

$7.80 premium

UndervaluedFair: $9.91Overvalued
PGSignificantly Overvalued (-53.8%)

Margin of Safety

-53.8%

Fair Value

$99.13

Current Price

$146.54

$47.41 premium

UndervaluedFair: $99.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

PG5 strengths · Avg: 9.2/10
Market CapQuality
$350.36B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
30.6%10/10

Every $100 of equity generates 31 in profit

Altman Z-ScoreHealth
3.0110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
23.1%8/10

Strong operational efficiency at 23.1%

Free Cash FlowQuality
$3.03B8/10

Generating 3.0B in free cash flow

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

PG1 concerns · Avg: 2.0/10
PEG RatioValuation
4.202/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : PG

The strongest argument for PG centers on Market Cap, Return on Equity, Altman Z-Score. Profitability is solid with margins at 19.2% and operating margin at 23.1%.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : PG

The primary concerns for PG are PEG Ratio.

Key Dynamics to Monitor

KVUE profiles as a value stock while PG is a mature play — different risk/reward profiles.

KVUE carries more volatility with a beta of 0.50 — expect wider price swings.

PG is growing revenue faster at 7.4% — sustainability is the question.

PG generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (68/100 vs 59/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Procter & Gamble Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.

Visit Website →

Want to dig deeper into these stocks?